Author

Ryan T. Brownlee

Mercer UniversityORCID 0000-0002-8516-8210Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Bradley K. YoderiD· 1 shared Brittany N. LasseigneiD· 1 shared Elizabeth J. WilkiD· 1 shared Hannah L. ClearyiD· 1 shared James F. GeorgeiD· 1 shared Jennifer L. FisheriD· 1 shared Kasi C. McPhersoniD· 1 shared Michal M. MrugiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Bradley K. YoderORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion

Elizabeth J. Wilk, Timothy C. Howton, Jennifer L. Fisher, Vishal H. Oza, Ryan T. Brownlee, Kasi C. McPherson, Hannah L. Cleary, Bradley K. Yoder, James F. George, Michal M. Mrug, Brittany N. Lasseigne

The paper identifies drug targets and repurposing candidates for ADPKD by analyzing gene expression signatures from mouse Pkd2 models using signature reversion.

bioRxiv · Dec 2, 2022 · PreprintGenomics